Balyasny Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-50,000
Closed -$8.86M 1638
2020
Q1
$8.86M Sell
50,000
-83,600
-63% -$15.7M 0.11% 265
2019
Q4
$25.5M Buy
+133,600
New +$24.1M 0.15% 204
2018
Q4
Sell
-134,000
Closed -$25.2M 1931
2018
Q3
$25.2M Buy
+134,000
New +$24.6M 0.11% 248
2018
Q1
Sell
-30,000
Closed -$4.91M 2477
2017
Q4
$4.91M Buy
+30,000
New +$5.38M 0.02% 867
2016
Q3
Sell
-60,000
Closed -$13.9M 1375
2016
Q2
$13.9M Sell
60,000
-40,000
-40% -$9.22M 0.09% 287
2016
Q1
$26.8M Buy
+100,000
New +$28.6M 0.16% 197
2014
Q2
Sell
-50,000
Closed -$10.3M 832
2014
Q1
$10.3M Buy
+50,000
New +$9.9M 0.12% 221

Other funds holding AGN

Balyasny Asset Management's AGN Position: Q2 2020 in Review

Balyasny Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 521,560 shares — an estimated $92.4M sold.

Balyasny Asset Management first reported a position in AGN in Q2 2013 and held it in 25 quarters. The position peaked at $118M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Balyasny Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Balyasny Asset Management sold 521,560 Allergan plc shares in Q2 2020, an estimated $92.4M.
  • Balyasny Asset Management first reported a position in Allergan plc in Q2 2013 and held it in 25 quarters.
  • Balyasny Asset Management's Allergan plc position peaked at $118M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Balyasny Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.